Crohn's & Colitis Foundation
Sharon Saias has a diverse work experience in marketing and communications. Sharon most recently worked as the VP of Marketing and Communications at the Crohn's & Colitis Foundation. In this role, they transformed and built a marketing team to support all departments within the organization. Prior to that, they served as the Assistant Director of Development at AJC Global, where they made an impact on important issues facing the Jewish people. Sharon also worked at Mount Sinai Health System as the Brand Director, leading strategic brand development and marketing efforts. Before that, they were the Vice President of Marketing and Communications at the Multiple Myeloma Research Foundation, where they built a marketing organization to support various business units. Sharon has also worked at Kraft Foods Group as a Senior Brand Manager, overseeing integrated marketing programs for the Gevalia brand. Additionally, they have experience at illy caffè North America, Inc. as the Ecommerce Direct to Consumer Marketing Manager, launching and managing the company's direct-to-consumer channel. Sharon started their career at Readers Digest Association as a Manager of Marketing Operations and later worked at Ogilvy & Mather Direct as a VP Management Supervisor.
Sharon Saias holds a Bachelor of Business Administration (BBA) degree in Marketing from Hofstra University. The specific duration of their education and any other educational experiences outside of this information are unknown.
Crohn's & Colitis Foundation
5 followers
The Crohn's & Colitis Foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life for the millions of Americans living with IBD. Our work is dramatically accelerating the research process through our database and investment initiatives; we also provide extensive educational resources for patients and their families, medical professionals, and the public.